This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
CAPLYTA® (lumateperone)
Medical Information
Use in Bipolar Depression (Bipolar Disorder I and II)
Last Updated: 04/06/2026
Summary
A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:
- CAPLYTA – Use in Bipolar Depression (Bipolar Disorder I and II)
- Minimum requirement to access interactive content: Adobe Acrobat Reader
- The executive summary infographic of the iPDF content is provided below.
